10x Genomics Launches BEAM to Improve and Streamline Antibod

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the commercial...

Related Keywords

, Ben Hindson , Bryan Briney , Exchange Commission , Professor At Scripps Research Institute , Genomics Inc , Securities Exchange , Nasdaq , Barcode Enabled Antigen Mapping , Chromium Single Cell Immune Profiling , Chief Scientific Officer , Assistant Professor , Scripps Research , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Financial Condition , 10x Genomics , Nc ,